Manejo de secreciones no invasivo en un paciente con Esclerosis Lateral Amiotrófica no colaborador, ¿dónde está el límite? A propósito de un caso

Balañá Corberó, A; Alvarado Miranda, M N; Bertran Recasens, B; Rovira Ribalta, N; Martínez Llorens, J.
Fisioterapia (Madr., Ed. impr.) ; 44(2): 123-126, mar.-abr. 2022. ilus
Artículo en Español | IBECS (España) | ID: ibc-203753

Documentos relacionados

  1. Advanced Imaging Approaches to Reveal Molecular Mechanisms Governing Neuroendocrine Secretion.
  2. Homogeneously catalytic oxidation of phenanthrene by the reaction of extracellular secretions of pyocyanin and Nicotinamide Adenine Dinucleotide.
  3. Optimized LC-MS/MS Method for the Detection of ppCCK(21-44): A Surrogate to Monitor Human Cholecystokinin Secretion.
  4. The Love and Hate Relationship between T5SS and Other Secretion Systems in Bacteria.
  5. An Alternative Application of Magnetic-Activated Cell Sorting: CD45 and CD235a Based Purification of Semen and Testicular Tissue Samples.
  6. A screen of brain organoids to study neurodevelopmental disease.
  7. Perforación cecal por angiostrongiliasis en un adulto mayor
  8. True nectar or stigmatic secretion? Structural evidence elucidates an old controversy regarding nectaries in Anthurium.
  9. Quantitative Proteomic Analysis of the Slime and Ventral Mantle Glands of the Striped Pyjama Squid (<i>Sepioloidea lineolata</i>).
  10. Molecular evolution of gland cell types and chemical interactions in animals.